All attending UK organisations

UK companies attending Bio-Europe 2016 as part of the official delegation

(Click here to search profiles):

UK Exhibitors
BioPartner UK, Dora Wirth Languages, Department for International Trade London Region
CRA (Charles River Associates), Cobra Biologics, Evaluate, FUJIFILM Diosynth Biotechnologies, GlobalData, GlaxoSmithKline, London & Partners, Mayor's International Business Programme, MedCity

UK stand (booth 55,56): 
Cambridge Research Biochemicals, Canbex Therapeutics, Cell and Gene Therapy Catapult, Censo Biotechnologies, CIMYM BioSciences, Clinical Network Services (CNS), Crescendo Biologics, Crystec, Datatrial, Dora Wirth (Languages), Edinburgh Molecular Imaging, First Derivatives, Fusion Antibodies, Glythera, High Force Research, IDACO Consulting, Karma Oncology, Medherant, MGB Biopharma, Mirador Analytics, Mironid, Nascient, Propath UK, Quay Pharmaceuticals, Scottish Development International, Seda Pharmaceutical Development Services, Selcia, Sharp Clinical Services, SiSaf, Synpromics, SYNthesis Research, The Research Network, Ubiquigent, United Life Sciences (BioPartner, BIA, Bionow, MediWales, One Nucleus)

Regional Groups:
London Region (booth 57) - Biotech and Money, CTRL Group, Department for International Trade London, ERA Consulting, Formuli, Image Analysis, Nanomerics, Pharmidex, Phastar, Richmond Pharmacology, SCIAD, Seven Bridges, Strategy in Life Sciences, Tecrea, Therakind, Touchlight.
Northern Ireland - Almac Discovery, Almac Group, Fusion Antibodies, SiSaf, Ulster University - Research and Innovation.
North of England - Crystec, Cambridge Research Biochemicals, Datatrial, Glythera, High Force Research, Mawdsleys, Seda Pharmaceutical Development Services
Scotland - BioAscent Discovery, Cyclacel, Edinburgh Molecular Imaging, Epidarex Capital, Iomet, Karma Oncology, Lamellar Biomedical, MGB Biopharma, Mirador Analytics, Mironid, Scottish Development International, Synpromics, Tepnel Pharma Services/Hologic, Tissue Solutions, Ubiquigent, University of Dundee - Research and Innovation Services, University of Strathclyde - Institute of Pharmacy and Biomedical Sciences.
Wales -  MediWales, Quay Pharmaceuticals, Sharp Clinical Services.

Other UK companies associated with the delegation*:
Abzena, Alacrita, Animalcare, Britannia Pharmaceuticals, Cello Health Consulting, Chiltern, Circassia, CLINICAL ACCELERATOR, Horizon Discovery, Imanova, Instinctif Partners, Jazz Pharmaceuticals, Koi Consulting Partners, Mundipharma International, ProImmune, Sygnature Discovery, Symbiosis Pharma, Tepnel Pharma Services/Hologic, Torreya Partners, Domainex, FranceMed Pharma, KWS BioTest, Mawdseys, Sareum, Symbiosis, UCB

UK Presenting companies:
4D Pharma Plc, Edinburgh Molecular Imaging, Ipsen Biopharm, Karus Therapeutics, Molecular Warehouse, Oxford BioTherapeutics, Peptinnovate, Shin Poong Pharma, Shire, Topivert Pharma, Verona Pharma plc

All attending UK companies:
3M United Kingdom PLC, 4D Pharma Plc, Abingworth, Abzena, AGales Consulting, Alacrita, Almac Group, Animalcare, Antev, Apex Helathcare Consulting, Apitope, ARCINOVA, AstraZeneca, Atelix, Atlantic Healthcare plc, Auspherix, Autolus, Baby2Body, Barrington James, Benevolent.AI, BioAscent Discovery, BioPartner UK, BioPharm Insight, Biopharma Group, Biotech and Money, Biotecnol Limited, BRISTOWS LLP, Britannia Pharmaceuticals, BTG plc, Cambridge Cognition, Cambridge Research Biochemicals, Canbex Therapeutics, Cancer Research Technology, Cell and Gene Therapy Catapult, Cell Medica, Cello Health Consulting, Censo Biotechnologies, Chiltern, Chronos Therapeutics, CIMYM BioSciences, Circassia, Citigate Dewe Rogerson, Clarivate Analytics (formerly the IP & Science business of Thomson Reuters), CLINICAL ACCELERATOR, Clinical Network Services (CNS), Clinigen Group plc, Cobra Biologics, Colliers International, Concept Life Sciences, Consilient Health, Covance, CPL Executive Search, CRA International (UK), Crescendo Biologics, Cresset Discovery Services, Critical Pharmaceuticals, Crystec, CTRL Group, Curileum Discovery Ltd, Cyclacel, Datatrial, Decision Resources Group, Denceptor Therapeutics, Dept Int Trade London (Business is GREAT), Diabetology, DISHMAN EUROPE, Domainex, Dora Wirth (Languages), Edinburgh Molecular Imaging, EGAMID, Eisai, Eli Lilly & Company, ELIXIR, EnlightMedical, Enterprise Therapeutics, EP Vantage, Epidarex Capital, ERA Consulting UK, ERGOMED PLC, ERT, Esperante, EUSA Pharma, Evaluate, Evgen Pharma PLC, Ferghana Partners, First Derivatives, Formuli, FranceMed Pharma, F-star Biotechnology, Fundamental VR, Fusion Antibodies, Galen, GBI Research (Global Data), GE Healthcare Life Sciences, Genetic Microdevices, Gilead Sciences, GlobalData, Glythera, Gowling WLG (UK) LLP, GSK, Guidepoint, HC Pharma Consultancy, High Force Research, Horizon, hVIVO, IDACO, Image Analysis, Imanova, ImmuPharma plc, Imperial Innovations, IMS Health, InClinica, Innovation Forum, Instinctif Partners, Institute of Cancer Research, Intract Pharma, Iomet, IONTAS, Jazz Pharmaceuticals, Jellagen Pty, Kanteron Systems, Karma Oncology, Karus Therapeutics, Koi Consulting Partners, Korn Ferry Futurestep, Kreos Capital, KWS BioTest, Kymab, Lamellar Biomedical, Life Sciences Hub Wales, London & Partners, London Mayor's International Business Programme, Manentia, Martindale Pharma, Mawdsleys, MedCity, Medherant, MEDICXI, Medius Associates, MedPharm, Merck UK & Ireland, Mergermarket Group, Merrill DataSite, MGB Biopharma, Midatech Pharma Plc, Mirador Analytics, Mironid, Mission Therapeutics, Molecular Warehouse, Mundipharma International, MVM Life Science Partners LLP, Nanomerics, Napp Pharmaceuticals, Nascient, Nature Publishing Group, NDA Group, NeRRe Therapeutics, Norgine, Norgine Ventures, Novasecta, OBN (UK), One Nucleus, ONO PHARMA UK, Orbit Discovery, Orca Pharmaceuticals, Osborne Clarke, Oxford Biomedica, Oxford BioTherapeutics, Oxford Genetics, PAREXEL Consulting, PatSnap, Peptinnovate, Pharma publications, Pharmalicensing, PharmaVentures, Pharmidex, Phastar, Phlexglobal, PRA Health Sciences, Premier Research, ProAxsis, Progenitor Labs Ltd, ProImmune ., Propath UK, Proximagen, PsiOxus Therapeutics, Quay Pharmaceuticals, Queen Mary University of London - Queen Mary Innovation, Quintiles, Redx Pharma Plc, Re-Pharm, Results Healthcare, Richmond Pharmacology, Sachs Associates, Sage Group, Samedan, Sareum, SCIAD, Scottish Development International, Scrip, Pink Sheet, In Vivo, Seda Pharmaceutical Development Services, Sekisui Diagnostics, Selcia, Seven Bridges, Sharp Clinical Services, Shin Poong Pharma, Shire, Sidley Austin, SILENCE THERAPEUTICS, Simbec-Orion Group, SiSaf, Sixth Element Capital LLP, Spencer Stuart, Strategy in Life Sciences, Stratophase, Substipharm, Summit Therapeutics plc, SV Life Sciences, Sygnature Discovery, Symbiosis Pharma, Synexus Clinical Research, Synpromics, SYNthesis Research, Taylor Wessing LLP, Tecrea, Teijin Pharma, Tepnel Pharma Services/Hologic, The Fulford Group, The Research Network Ltd, The University of Nottingham, Therakind, Thomson Reuters, Tissue Solutions, Topivert Pharma, Torreya Partners, Touchlight, Transcriptogen  (TGEN), Trimunocor, Tusk Therapeutics, Ubiquigent, UCB, UK BioIndustry Association (BIA), Ulster University - Research and Innovation, United Life Sciences, University College of London, University of Dundee - Research and Innovation Services, University of Strathclyde - Institute of Pharmacy and Biomedical Sciences, ValiSeek, VCLS, Vectura, Vernalis plc, Verona Pharma plc, Viramal, Viramatix, Visium Healthcare Partners, Wellcome Trust Sanger Institute, WuXi Apptec
(255)

Join them here!